Source to Pay Insights Intern

Takeda Pharmaceutical Company Limited Lodz, PL Posted Aug 11, 2026
Location
Lodz, PL
Workplace
On-site / per employer
Posted
Aug 11, 2026

About this role

By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms of Use . I further attest that all information I submit in my employment application is true to the best of my knowledge. Job Description About the Role: As a Source to Pay (S2P) Insights Intern, you will support the team in transforming procurement data into meaningful insights that help drive performance and decision-making.

This internship offers a hands-on opportunity to learn about data analytics, procurement processes, and stakeholder collaboration in a global business environment. Key Responsibilities: Assist in collecting, organizing, and analyzing procurement and S2P data. Support the creation of dashboards and reports using tools like Excel and Power BI.

Collaborate with team members to understand business needs and translate them into data-driven insights. Help ensure data accuracy and relevance for reporting and decision-making. Participate in meetings and contribute to discussions on process improvements and reporting enhancements.

What We’re Looking For: Interest in data analysis, business processes, or procurement. Basic knowledge of Excel; familiarity with Power BI or similar tools is a plus. Analytical mindset with attention to detail.

Willingness to learn and collaborate in a team environment. Good communication skills in English. What You’ll Gain: Exposure to real-world business analytics and procurement operations.

Experience working in a global, cross-functional team. Development of technical and soft skills in a supportive environment. Locations Lodz, Poland Worker Type Employee Worker Sub-Type Unpaid Intern (Fixed Term) (Trainee) Time Type Part time

Originally posted by Takeda Pharmaceutical Company Limited. View original posting